Déclaration de l'UE en réponse au rapport du Chef de la Mission de l'OSCE en République de Moldavie, S.E. l’Ambassadeur Michael Scanlan
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
The Schedule (which amends the Pharmacy Act 1954 for the purposes mentioned below and makes consequential amendments) is to have effect.
Those purposes are—
establishing a new committee of the Royal Pharmaceutical Society of Great Britain,
enabling the committee to consider allegations against registered pharmaceutical chemists of unfitness to practise due to ill health, and
enabling the committee to impose practising conditions on, or suspend from registration, registered pharmaceutical chemists whose ability to practise it finds to be seriously impaired due to ill health.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Section 1 and the Schedule are to come into force on such day as the Secretary of State may by order made by statutory instrument appoint.
Different days may be appointed for different purposes.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
This Act may be cited as the Pharmacists (Fitness to Practise) Act 1997.
This Act (except paragraph 5 of the Schedule) does not extend to Northern Ireland.
Section 1.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“conditions of practice order” has the meaning given by section 13C(2)(a) of this Act
“interim suspension order” has the meaning given by section 13F(1) of this Act
“suspension order” has the meaning given by section 13C(2)(b) of this Act
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
in subsection (1), after “Subject to” there is inserted “subsection (1A) below and”, and
after subsection (1) there is inserted—
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .